Skip to main content

Table 2 Survival rate of NPC patients with N3 disease

From: Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma

Three years

All Patients

Chemoradiotherapy-non-MC Patients (n = 109)

Chemoradiotherapy-MC Patients (n = 21)

χ2

p value

OS

79.2%

76.3%

95.2%

2.999

0.046

DMFS

73.6%

70.3%

90.5%

4.111

0.043

LFFS

88.2%

84.9%

100%

2.851

0.091

  1. Abbreviations: MC Maintenance chemotherapy, OS Overall survival, DMFS Distant metastasis-survival, LFFS Locoregional failure-free survival
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us